- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/28 - 1,4-OxazinesHydrogenated 1,4-oxazines
Patent holdings for IPC class C07D 265/28
Total number of patents in this class: 64
10-year publication summary
|
3
|
7
|
2
|
3
|
6
|
3
|
3
|
2
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 737 |
4 |
| Ricoh Company, Ltd. | 13305 |
2 |
| Adverio Pharma GmbH | 46 |
2 |
| Alcon, Inc. | 5677 |
2 |
| BioCryst Pharmaceuticals, Inc. | 179 |
2 |
| Oregon Health & Science University | 751 |
2 |
| ProteinSimple | 92 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 855 |
2 |
| West China Hospital, Sichuan University | 218 |
2 |
| Kemimedi Co.Ltd | 3 |
2 |
| Cullgen (Shanghai), Inc. | 40 |
2 |
| Merck Sharp & Dohme LLC | 3702 |
2 |
| Glaxosmithkline LLC | 533 |
1 |
| Hoffmann-La Roche Inc. | 3665 |
1 |
| Baker Hughes Incorporated | 5057 |
1 |
| 3m Innovative Properties Company | 17536 |
1 |
| BASF SE | 21127 |
1 |
| The Regents of the University of California | 20473 |
1 |
| International Business Machines Corporation | 62148 |
1 |
| Honeywell International Inc. | 13543 |
1 |
| Other owners | 30 |